Cancer microRNAs: from subtype profiling to predictors of response to therapy
about
MicroRNAS in endometrial cancer: recent advances and potential clinical applicationsThe miR-200 Family: Versatile Players in Epithelial Ovarian CancerEmerging therapeutic biomarkers in endometrial cancerCirculating microRNAs as biomarkers, therapeutic targets, and signaling moleculesA microRNA code for prostate cancer metastasis.microRNA-1/133a and microRNA-206/133b clusters: dysregulation and functional roles in human cancers.The effects of MicroRNA transfections on global patterns of gene expression in ovarian cancer cells are functionally coordinated.Important miRs of pathways in different tumor types.Effects of preanalytic variables on circulating microRNAs in whole blood.MIR376A is a regulator of starvation-induced autophagy.Circulating MicroRNA as Biomarkers: An Update in Prostate Cancer.ACVR1, a therapeutic target of fibrodysplasia ossificans progressiva, is negatively regulated by miR-148a.Clinical Impact of a Novel MicroRNA Chemo-Sensitivity Predictor in Gastrooesophageal Cancer.Molecular targeting of protein arginine deiminases to suppress colitis and prevent colon cancerMicroRNA in TLR signaling and endotoxin tolerance.MAPK Signal Transduction Pathway Regulation: A Novel Mechanism of Rat HSC-T6 Cell Apoptosis Induced by FUZHENGHUAYU TabletInhibition of MicroRNA miR-222 with LNA Inhibitor Can Reduce Cell Proliferation in B Chronic Lymphoblastic Leukemia.The Profile of Serum microRNAs Predicts Prognosis for Resected Gastric Cancer Patients Receiving Platinum-Based Chemotherapy.MicroRNA-31 Regulates Chemosensitivity in Malignant Pleural MesotheliomaIsoliquiritigenin modulates miR-374a/PTEN/Akt axis to suppress breast cancer tumorigenesis and metastasis.Association of the miR-146aC>G, miR-149T>C, miR-196a2T>C, and miR-499A>G polymorphisms with gastric cancer risk and survival in the Korean population.Mathematical modeling and computational prediction of cancer drug resistance.miR-101-2, miR-125b-2 and miR-451a act as potential tumor suppressors in gastric cancer through regulation of the PI3K/AKT/mTOR pathway.MicroRNA-106b modulates epithelial-mesenchymal transition by targeting TWIST1 in invasive endometrial cancer cell lines.miR-222 promotes invasion and migration of ovarian carcinoma by targeting PTEN.
P2860
Q26780358-C7EEA2CB-D216-4003-AB40-EB32FF246DA3Q26799353-15FD8AFA-3C94-4BC1-B5C3-FCE0F3BBAA27Q26865904-1A26F533-891E-4D06-AD5C-43AA56085913Q26997097-0A42AA4D-ABA6-4872-82EC-6279D761E187Q27310006-34CB46F4-468F-4E49-BC2D-80642D72A3F7Q34252329-7283B946-03BE-482F-83F3-A1DB1FD922CAQ34361840-B7BF9506-D956-4B90-A256-16D0292203DAQ34566039-F403AAC3-73E9-470A-93E9-277B4C36A234Q34635975-F7261172-77D2-4011-BB54-40777E71DE17Q35072844-1195134A-1C84-4652-BF0C-BF7ED043D921Q35780870-B79608D8-C8E0-447A-AAF8-6C36DC868D0FQ35795849-56000F77-8C6B-4E08-B9F5-3C3D2782A5D7Q35925992-45008391-BC63-4648-9A7B-F8B5E6D5CBAAQ36546562-F9ED9C49-9B60-4634-850A-DA0095FA4AD1Q36745742-14E5A6D6-E246-4C85-88A9-A091965614D3Q36896262-7107C968-C6AF-4E33-8738-4A73C0FABC1BQ38616907-B375E452-2B0A-47A3-B0B9-008401A71355Q38710597-4E6C201C-E0B4-4F42-B91F-760844655719Q41191000-1D2BF863-1CE6-4FB2-AFFD-F855A0F8954FQ41488865-6982D86F-078B-43BC-A6E1-C46E896C10B7Q45118174-F8A92D17-D280-464E-ACAA-C8BC552A6CCFQ47660509-3B2B858C-1223-4670-9B00-91AFA18D9C33Q53314337-F475543E-2921-4A1F-9EDA-D430A0A74DEBQ54244950-0DF702EB-C00D-450F-ABC5-64A896F73E97Q55430716-323CC530-09D0-4EE5-9837-1E580D816DE9
P2860
Cancer microRNAs: from subtype profiling to predictors of response to therapy
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Cancer microRNAs: from subtype profiling to predictors of response to therapy
@ast
Cancer microRNAs: from subtype profiling to predictors of response to therapy
@en
Cancer microRNAs: from subtype profiling to predictors of response to therapy
@nl
type
label
Cancer microRNAs: from subtype profiling to predictors of response to therapy
@ast
Cancer microRNAs: from subtype profiling to predictors of response to therapy
@en
Cancer microRNAs: from subtype profiling to predictors of response to therapy
@nl
prefLabel
Cancer microRNAs: from subtype profiling to predictors of response to therapy
@ast
Cancer microRNAs: from subtype profiling to predictors of response to therapy
@en
Cancer microRNAs: from subtype profiling to predictors of response to therapy
@nl
P2860
P1476
Cancer microRNAs: from subtype profiling to predictors of response to therapy
@en
P2093
Daniel Estévez Prado
Elcie Chan
P2860
P304
P356
10.1016/J.MOLMED.2011.01.008
P407
P577
2011-05-01T00:00:00Z